Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Isomer-Resolved Imaging of Prostate Cancer Tissues Reveals Specific Lipid Unsaturation Profiles Associated With Lymphocytes and Abnormal Prostate Epithelia

Frontiers in Endocrinology(2021)10.3389/fendo.2021.689600Source: DataRank Database

Isomer-Resolved Imaging of Prostate Cancer Tissues Reveals Specific Lipid Unsaturation Profiles Associated With Lymphocytes and Abnormal Prostate Epithelia is a research paper published in Frontiers in Endocrinology (2021). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.65)OA: goldTopics (68)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Britt S. R. Claes ORCID,Andrew P. Bowman ORCID,Elizabeth D. Williams ORCID,Benjamin Shepherd,Aurel Perren ORCID

Live enrichment

PubMed:34421820 PMC:PMC8374165 OpenAlex:https://openalex.org/W3187532787

Australian Research Council (ARC)

Grant: DP190101486

Discovery Projects - Grant ID: DP190101486

Australian Research Council (ARC)

Grant: FT190100082

ARC Future Fellowships - Grant ID: FT190100082

National Institutes of Health

Grant: 5R01CA213492-05

Hypoxia-derived molecular MSI signatures to predict breast cancer outcome

Australian Research Council (ARC)

Grant: LP180100238

Linkage Projects - Grant ID: LP180100238

FWCI

1.65

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fendo.2021.689600/pdf

GOLDhttps://www.frontiersin.org/articles/10.3389/fendo.2021.689600/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fendo.2021.689600/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fendo.2021.689600/full

journalhttps://doi.org/10.3389/fendo.2021.689600

Fields of Study

Cancer, Lipids, and MetabolismMetabolomics and Mass Spectrometry StudiesMass Spectrometry Techniques and ApplicationsMedicineBiologyChemistry0301 basic medicine03 medical and health sciences0303 health sciencesEpithelial CellsHumansLipid MetabolismLipidomicsLymphocytesMaleMass SpectrometryProstateProstatectomyProstatic Neoplasms

MeSH Terms

LipidomicsEpithelial CellsHumansLymphocytesMaleProstateProstatectomyProstatic NeoplasmsMass SpectrometryLipid Metabolism

Keywords

Prostate cancerPathologyProstateMass spectrometry imagingDegree of unsaturationLipidomicsHistopathologyLipid metabolismProstatectomyCancerBiopsyChemistryGrading (engineering)Cancer researchBiologyMedicineBiochemistryInternal medicineMass spectrometryLipidImagingMaleQUANTITATIONEndocrinology, Diabetes and Metabolism610Diseases of the endocrine glands. Clinical endocrinologyEndocrinologyHumansLymphocytesTHERAPEUTIC TARGETIDENTIFICATIONELUCIDATIONProstatic NeoplasmsEpithelial CellsMASS-SPECTROMETRYOZONE-INDUCED DISSOCIATIONRC648-665COA DESATURASE 1PALMITOLEIC ACID

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being